We are thrilled to see DNlite's predictive technology increasingly adopted by primary care clinics across Taiwan, delivering true precision medicine to patients with diabetes.
Recently, Dr. Hung-Lin Chen, President of the Taiwan Primary Care Diabetes Association, was featured in an exclusive interview with Hello Yishi (a leading health media platform) to discuss the paradigm shift in combating Chronic Kidney Disease (CKD).
In the interview, Dr. Chen highlighted a critical message: "We must transition from passive treatment to proactive prediction." He emphasized how innovative biomarkers like DNlite empower primary care physicians to overcome the diagnostic blind spots of traditional tests, identifying high-risk patients long before irreversible structural damage occurs.
????️ Watch the highlight reel (Mandarin) to see how DNlite is changing the game in primary care:
* Facebook:https://www.facebook.com/share/1C5E1mJbWN/
* Youtube:https://www.youtube.com/watch?v=26xnJFSDXpA
* Eventsite:https://helloyishi-event.com/event.php?id=10
Related News
BPM’s Cross-Ethnic DKD Clinical Study Published in Top-Tier American Journal of Nephrology
Paving the Way for US Market Entry
2023/10/13
Press
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
2023/12/08
Press
BPM's DNlite-IVD103 Secures Regulatory Approval from UAE MoHAP, Accelerating Middle East Market Penetration
BPM's DNlite-IVD103 Secures Regulatory Approval from UAE MoHAP, Accelerating Middle East Market Penetration
2024/02/27
Press